Nemaura (NMRD) Set To Launch SugarBEAT® CGM To All Diabetics, Pre-Diabetics & Insulin-Users

Sep. 12, 2018
Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible glucose trending ...

 Read More


"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market